Your browser doesn't support javascript.
loading
A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.
Shultz, David B; Pai, Jonathan; Chiu, Wayland; Ng, Kendall; Hellendag, Madeline G; Heestand, Gregory; Chang, Daniel T; Tu, Dongsheng; Moore, Malcolm J; Parulekar, Wendy R; Koong, Albert C.
Afiliação
  • Shultz DB; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Pai J; School of Medicine, University of California San Francisco, San Francisco, United States of America.
  • Chiu W; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America.
  • Ng K; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America.
  • Hellendag MG; Kaiser Permanente Medical Center, San Francisco, United States of America.
  • Heestand G; Moores Cancer Center, University of California San Diego, La Jolla, CA, United States of America.
  • Chang DT; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America.
  • Tu D; NCIC Clinical Trials Group, Queen's University, Kingston, Canada.
  • Moore MJ; British Columbia Cancer Agency, Vancouver, British Columbia, CA, United States of America.
  • Parulekar WR; NCIC Clinical Trials Group, Queen's University, Kingston, Canada.
  • Koong AC; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, United States of America.
PLoS One ; 11(1): e0147995, 2016.
Article em En | MEDLINE | ID: mdl-26808546
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Biomarcadores Tumorais / Desoxicitidina / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Biomarcadores Tumorais / Desoxicitidina / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá